Skip to content
TrialScanner

NCT02586168

The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects

Phase 2CompletedMTVALead

Registry record

Lead sponsor
NeuroBo Pharmaceuticals Inc.
Conditions
Insulin Sensitivity
Primary completion
Oct 2001Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02586168 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02586168: The Effect of Gemcabene on... | TrialScanner